---
title: '2015 and before (4)'
collection: publications
permalink: /publications/publication_list_2015before
---

<p>[1] Mony JT, Zhang L, <b>Ma, T </b>, Grabosch S, Tirodkar TS, Boric J, Tseng G, Elishaev E, Edwards RP, Huang X and Vlad AM. (2015). Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model. <i>Cancer Immunology, Immunotherapy</i> 64(9):1095-108. doi: 10.1007/s00262-015-1712-6 <a href="https://www.ncbi.nlm.nih.gov/pubmed/25998800">PMID: 25998800</a>. 
<p>[2] Liao S, Hartmaier RJ, McGuire KP, Puhalla SL, Luthra S, Chandran UR, <b>Ma, T </b>, Bhargava R, Davidson NE, Benz S, Lee AV, Tseng GC and Oesterreich S. (2015). The molecular landscape of premenopausal breast cancer. <i>Breast Cancer Research</i>, 17:104. doi: 10.1186/s13058-015-0618-8. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26251034">PMID: 26251034</a>. (discussed in an interview; <a href="http://www.nature.com/nature/journal/v527/n7578_supp/full/527S108a.html"><i>Nature</i>, 527: S108-109</a>)
<p>[3] Suryawanshi S, Huang X, Elishaev E, Budiu RA, Zhang L, Kim S, Donnellan N, Mantia-Smaldone G, <b> Ma, T.</b>, Tseng G, Lee T, Mansuria S, Edwards RP and Vlad AM. (2014). Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer, <i>Clinical Cancer Research</i>, 20(23):6163-6174. doi: 10.1158/1078-0432.CCR-14-1338. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25294912">PMID: 25294912</a>. 
<p>[4] Hou, L.*, <b> Ma, T.</b>*, and Zhao, H. (2014). Incorporating functional annotation information in prioritizing disease associated SNPs from genome wide association studies. <i>Science China Life Sciences</i>, 57(11): 1072-1079. (* co-first author)
